The firm announced the presentation of research highlighting the improved diagnostic capabilities of the TRUFORMA Bulk Acoustic Wave (BAW) platform when evaluating cats for thyroid disease compared to widely utilized chemiluminescent immunoassay (CLIA) platforms.
Zomedica Presents TRUFORMA(R) Research Findings At Major Veterinary Internal Medicine Conference, Says New Research Data Confirms Superiority Of TRUFORMA's Bulk Acoustic Wave Sensor Technology In Diagnosing Feline Hyperthyroidism
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.